CytoDyn (CYDY) Long-Term Debt Issuances (2013 - 2025)

CytoDyn (CYDY) posted Long-Term Debt Issuances of $142000.0 for Q3 2025, down 80.0% on a QoQ basis from $710000.0 in Q3 2024, and down 80.0% year-over-year from $710000.0 in Q3 2024.

CytoDyn (CYDY) Long-Term Debt Issuances (2013 - 2025) Analysis & Trends

CytoDyn's Long-Term Debt Issuances history runs 10 years deep, the most recent figure standing at $142000.0 for Q3 2025.

  • Quarterly Long-Term Debt Issuances fell 80.0% year-over-year to $142000.0 in Q3 2025, while the trailing twelve-month figure through Feb 2026 was $142000.0 (down 99.72% YoY) and the FY2025 annual result came in at $710000.0, changed N/A from the prior year.
  • Long-Term Debt Issuances was $142000.0 for Q3 2025 at CytoDyn, down from $710000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $50.0 million in Q2 2021 and bottomed at $142000.0 in Q3 2025.
  • A 3-year average of $17.0 million and a median of $710000.0 in 2024 frame the typical range for Long-Term Debt Issuances.
  • Annual changes were most pronounced in 2021 — Long-Term Debt Issuances soared 276.65% — and 2025, when it sank 80.0%.
  • CytoDyn's Long-Term Debt Issuances stood at $50.0 million in 2021, then tumbled by 98.58% to $710000.0 in 2024, then sank by 80.0% to $142000.0 in 2025.
  • Business Quant data shows CYDY's Long-Term Debt Issuances at $142000.0 in Q3 2025, $710000.0 in Q3 2024, and $50.0 million in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CytoDyn 267.79 Mn 267.79 Mn - -

Historic Data

Download Data
DateValue
Aug 31, 2025 142,000.00
Aug 31, 2025 142,000.00
Aug 31, 2024 710,000.00
Aug 31, 2024 710,000.00
May 31, 2021 50.00 Mn
May 31, 2021 50.00 Mn
Nov 30, 2020 25.00 Mn
Nov 30, 2020 25.00 Mn
Aug 31, 2020 25.00 Mn
Aug 31, 2020 25.00 Mn
May 31, 2020 13.28 Mn
May 31, 2020 13.28 Mn
Feb 29, 2020 1.73 Mn
Feb 29, 2020 1.73 Mn
Nov 30, 2019 700,000.00
Nov 30, 2019 700,000.00
May 31, 2019 -583,000.00
May 31, 2019 -583,000.00
Feb 28, 2019 10.46 Mn
Feb 28, 2019 10.46 Mn